Research News

Community Spotlight Research News

Key updates on Down syndrome community access to new Alzheimer’s drugs

Five takeaways for the Down syndrome community: Updates on accessing the new Alzheimer’s drugsLuMind IDSC…

Kate O’NeillJuly 7, 2023

Research News Research Spotlight

LuMind IDSC statement on FDA approval of Leqembi

LuMind IDSC issues statement following FDA full approval of Leqembi™ to treat early-stage Alzheimer’s disease …

Kate O’NeillJuly 7, 2023

Press Release Research News

MapHabit Study: Assistive Technology Has Positive Outcomes for Children with Down Syndrome

Study Finds Assistive Technology Has Positive Outcomes for Children with Down Syndrome and Their Caregivers …

Kate O’NeillJune 2, 2023

Research News Press Release Research Spotlight

Expert panel addresses inequitable access to Alzheimer’s drugs for adults with Down syndrome

Seeking to rectify existing federal and state policies which prevent people with intellectual disabilities from…

Kate O’NeillJune 1, 2023

Research News Research Spotlight

LuMind IDSC Statement re: Donanemab Phase 3 Results

Pharmaceutical company Eli Lilly today announced results of a phase III clinical trial that proves…

Kate O’NeillMay 3, 2023

Sleep Apnea and Down Syndrome, LuMind IDSC Foundation

Research Spotlight Research News Sleep Apnea

Important progress in the treatment of sleep apnea and Down syndrome

At the end of March, the US Food & Drug Administration approved Inspire’s Hypoglossal Nerve…

Kate O’NeillMarch 29, 2023

Research Spotlight Research News

Fierce Biotech article highlights dearth of inclusion in Alzheimer’s research

"Alzheimer's meds are here. But for the Down syndrome community, it's still the 1980s" by…

Kate O’NeillMarch 2, 2023

Tau Tangles in Down syndrome related Alzheimer's disease

Research Spotlight Press Release Research News

With support from Lilly, LuMind IDSC launches key research and awareness activities to advance Down syndrome research

2/22/2023 (Burlington, MA) – Today the LuMind IDSC Foundation, a leading national Down syndrome research…

Kate O’NeillFebruary 23, 2023

Research Spotlight Research News

Results from “Challenges of Caregiving” Survey Published in Research Journal

The LuMind IDSC community and caregivers across the U.S. participated in “Challenges of Caregiving,” an…

CapetivateJanuary 26, 2023

Research News Research Spotlight

New steps forward in treating Alzheimer’s disease with lecanemab: Clinical trial reveals clear efficacy in removing brain plaque

At an Alzheimer’s disease research conference last week, new clinical trial data was presented for…

Kate O’NeillDecember 5, 2022

Key updates on Down syndrome community access to new Alzheimer’s drugs

LuMind IDSC statement on FDA approval of Leqembi

MapHabit Study: Assistive Technology Has Positive Outcomes for Children with Down Syndrome

Expert panel addresses inequitable access to Alzheimer’s drugs for adults with Down syndrome

LuMind IDSC Statement re: Donanemab Phase 3 Results

Important progress in the treatment of sleep apnea and Down syndrome

Fierce Biotech article highlights dearth of inclusion in Alzheimer’s research

With support from Lilly, LuMind IDSC launches key research and awareness activities to advance Down syndrome research

Results from “Challenges of Caregiving” Survey Published in Research Journal

New steps forward in treating Alzheimer’s disease with lecanemab: Clinical trial reveals clear efficacy in removing brain plaque

Recent Posts

CONTACT LUMIND IDSC

QUICK LINKS

NEED MORE INFORMATION?